Global Amyotrophic Lateral Sclerosis (ALS) Market Growth 2024-2030

Report ID: 2862862 | Published Date: Jan 2025 | No. of Page: 97 | Base Year: 2024 | Rating: 4.8 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Scope of the Report

    1.1 Market Introduction

    1.2 Years Considered

    1.3 Research Objectives

    1.4 Market Research Methodology

    1.5 Research Process and Data Source

    1.6 Economic Indicators

    1.7 Currency Considered

    1.8 Market Estimation Caveats

2 Executive Summary

    2.1 World Market Overview

        2.1.1 Global Amyotrophic Lateral Sclerosis (ALS) Annual Sales 2019-2030

        2.1.2 World Current & Future Analysis for Amyotrophic Lateral Sclerosis (ALS) by Geographic Region, 2019, 2023 & 2030

        2.1.3 World Current & Future Analysis for Amyotrophic Lateral Sclerosis (ALS) by Country/Region, 2019, 2023 & 2030

    2.2 Amyotrophic Lateral Sclerosis (ALS) Segment by Type

        2.2.1 Riluzole

        2.2.2 Edaravone (Radicava)

        2.2.3 Other

    2.3 Amyotrophic Lateral Sclerosis (ALS) Sales by Type

        2.3.1 Global Amyotrophic Lateral Sclerosis (ALS) Sales Market Share by Type (2019-2024)

        2.3.2 Global Amyotrophic Lateral Sclerosis (ALS) Revenue and Market Share by Type (2019-2024)

        2.3.3 Global Amyotrophic Lateral Sclerosis (ALS) Sale Price by Type (2019-2024)

    2.4 Amyotrophic Lateral Sclerosis (ALS) Segment by Application

        2.4.1 Hospital

        2.4.2 Drugs Store

        2.4.3 Other

    2.5 Amyotrophic Lateral Sclerosis (ALS) Sales by Application

        2.5.1 Global Amyotrophic Lateral Sclerosis (ALS) Sale Market Share by Application (2019-2024)

        2.5.2 Global Amyotrophic Lateral Sclerosis (ALS) Revenue and Market Share by Application (2019-2024)

        2.5.3 Global Amyotrophic Lateral Sclerosis (ALS) Sale Price by Application (2019-2024)

3 Global Amyotrophic Lateral Sclerosis (ALS) by Company

    3.1 Global Amyotrophic Lateral Sclerosis (ALS) Breakdown Data by Company

        3.1.1 Global Amyotrophic Lateral Sclerosis (ALS) Annual Sales by Company (2019-2024)

        3.1.2 Global Amyotrophic Lateral Sclerosis (ALS) Sales Market Share by Company (2019-2024)

    3.2 Global Amyotrophic Lateral Sclerosis (ALS) Annual Revenue by Company (2019-2024)

        3.2.1 Global Amyotrophic Lateral Sclerosis (ALS) Revenue by Company (2019-2024)

        3.2.2 Global Amyotrophic Lateral Sclerosis (ALS) Revenue Market Share by Company (2019-2024)

    3.3 Global Amyotrophic Lateral Sclerosis (ALS) Sale Price by Company

    3.4 Key Manufacturers Amyotrophic Lateral Sclerosis (ALS) Producing Area Distribution, Sales Area, Product Type

        3.4.1 Key Manufacturers Amyotrophic Lateral Sclerosis (ALS) Product Location Distribution

        3.4.2 Players Amyotrophic Lateral Sclerosis (ALS) Products Offered

    3.5 Market Concentration Rate Analysis

        3.5.1 Competition Landscape Analysis

        3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)

    3.6 New Products and Potential Entrants

    3.7 Mergers & Acquisitions, Expansion

4 World Historic Review for Amyotrophic Lateral Sclerosis (ALS) by Geographic Region

    4.1 World Historic Amyotrophic Lateral Sclerosis (ALS) Market Size by Geographic Region (2019-2024)

        4.1.1 Global Amyotrophic Lateral Sclerosis (ALS) Annual Sales by Geographic Region (2019-2024)

        4.1.2 Global Amyotrophic Lateral Sclerosis (ALS) Annual Revenue by Geographic Region (2019-2024)

    4.2 World Historic Amyotrophic Lateral Sclerosis (ALS) Market Size by Country/Region (2019-2024)

        4.2.1 Global Amyotrophic Lateral Sclerosis (ALS) Annual Sales by Country/Region (2019-2024)

        4.2.2 Global Amyotrophic Lateral Sclerosis (ALS) Annual Revenue by Country/Region (2019-2024)

    4.3 Americas Amyotrophic Lateral Sclerosis (ALS) Sales Growth

    4.4 APAC Amyotrophic Lateral Sclerosis (ALS) Sales Growth

    4.5 Europe Amyotrophic Lateral Sclerosis (ALS) Sales Growth

    4.6 Middle East & Africa Amyotrophic Lateral Sclerosis (ALS) Sales Growth

5 Americas

    5.1 Americas Amyotrophic Lateral Sclerosis (ALS) Sales by Country

        5.1.1 Americas Amyotrophic Lateral Sclerosis (ALS) Sales by Country (2019-2024)

        5.1.2 Americas Amyotrophic Lateral Sclerosis (ALS) Revenue by Country (2019-2024)

    5.2 Americas Amyotrophic Lateral Sclerosis (ALS) Sales by Type

    5.3 Americas Amyotrophic Lateral Sclerosis (ALS) Sales by Application

    5.4 United States

    5.5 Canada

    5.6 Mexico

    5.7 Brazil

6 APAC

    6.1 APAC Amyotrophic Lateral Sclerosis (ALS) Sales by Region

        6.1.1 APAC Amyotrophic Lateral Sclerosis (ALS) Sales by Region (2019-2024)

        6.1.2 APAC Amyotrophic Lateral Sclerosis (ALS) Revenue by Region (2019-2024)

    6.2 APAC Amyotrophic Lateral Sclerosis (ALS) Sales by Type

    6.3 APAC Amyotrophic Lateral Sclerosis (ALS) Sales by Application

    6.4 China

    6.5 Japan

    6.6 South Korea

    6.7 Southeast Asia

    6.8 India

    6.9 Australia

    6.10 China Taiwan

7 Europe

    7.1 Europe Amyotrophic Lateral Sclerosis (ALS) by Country

        7.1.1 Europe Amyotrophic Lateral Sclerosis (ALS) Sales by Country (2019-2024)

        7.1.2 Europe Amyotrophic Lateral Sclerosis (ALS) Revenue by Country (2019-2024)

    7.2 Europe Amyotrophic Lateral Sclerosis (ALS) Sales by Type

    7.3 Europe Amyotrophic Lateral Sclerosis (ALS) Sales by Application

    7.4 Germany

    7.5 France

    7.6 UK

    7.7 Italy

    7.8 Russia

8 Middle East & Africa

    8.1 Middle East & Africa Amyotrophic Lateral Sclerosis (ALS) by Country

        8.1.1 Middle East & Africa Amyotrophic Lateral Sclerosis (ALS) Sales by Country (2019-2024)

        8.1.2 Middle East & Africa Amyotrophic Lateral Sclerosis (ALS) Revenue by Country (2019-2024)

    8.2 Middle East & Africa Amyotrophic Lateral Sclerosis (ALS) Sales by Type

    8.3 Middle East & Africa Amyotrophic Lateral Sclerosis (ALS) Sales by Application

    8.4 Egypt

    8.5 South Africa

    8.6 Israel

    8.7 Turkey

    8.8 GCC Countries

9 Market Drivers, Challenges and Trends

    9.1 Market Drivers & Growth Opportunities

    9.2 Market Challenges & Risks

    9.3 Industry Trends

10 Manufacturing Cost Structure Analysis

    10.1 Raw Material and Suppliers

    10.2 Manufacturing Cost Structure Analysis of Amyotrophic Lateral Sclerosis (ALS)

    10.3 Manufacturing Process Analysis of Amyotrophic Lateral Sclerosis (ALS)

    10.4 Industry Chain Structure of Amyotrophic Lateral Sclerosis (ALS)

11 Marketing, Distributors and Customer

    11.1 Sales Channel

        11.1.1 Direct Channels

        11.1.2 Indirect Channels

    11.2 Amyotrophic Lateral Sclerosis (ALS) Distributors

    11.3 Amyotrophic Lateral Sclerosis (ALS) Customer

12 World Forecast Review for Amyotrophic Lateral Sclerosis (ALS) by Geographic Region

    12.1 Global Amyotrophic Lateral Sclerosis (ALS) Market Size Forecast by Region

        12.1.1 Global Amyotrophic Lateral Sclerosis (ALS) Forecast by Region (2025-2030)

        12.1.2 Global Amyotrophic Lateral Sclerosis (ALS) Annual Revenue Forecast by Region (2025-2030)

    12.2 Americas Forecast by Country

    12.3 APAC Forecast by Region

    12.4 Europe Forecast by Country

    12.5 Middle East & Africa Forecast by Country

    12.6 Global Amyotrophic Lateral Sclerosis (ALS) Forecast by Type

    12.7 Global Amyotrophic Lateral Sclerosis (ALS) Forecast by Application

13 Key Players Analysis

    13.1 Mitsubishi Tanabe Pharma

        13.1.1 Mitsubishi Tanabe Pharma Company Information

        13.1.2 Mitsubishi Tanabe Pharma Amyotrophic Lateral Sclerosis (ALS) Product Portfolios and Specifications

        13.1.3 Mitsubishi Tanabe Pharma Amyotrophic Lateral Sclerosis (ALS) Sales, Revenue, Price and Gross Margin (2019-2024)

        13.1.4 Mitsubishi Tanabe Pharma Main Business Overview

        13.1.5 Mitsubishi Tanabe Pharma Latest Developments

    13.2 Sanofi

        13.2.1 Sanofi Company Information

        13.2.2 Sanofi Amyotrophic Lateral Sclerosis (ALS) Product Portfolios and Specifications

        13.2.3 Sanofi Amyotrophic Lateral Sclerosis (ALS) Sales, Revenue, Price and Gross Margin (2019-2024)

        13.2.4 Sanofi Main Business Overview

        13.2.5 Sanofi Latest Developments

    13.3 Mylan Pharma

        13.3.1 Mylan Pharma Company Information

        13.3.2 Mylan Pharma Amyotrophic Lateral Sclerosis (ALS) Product Portfolios and Specifications

        13.3.3 Mylan Pharma Amyotrophic Lateral Sclerosis (ALS) Sales, Revenue, Price and Gross Margin (2019-2024)

        13.3.4 Mylan Pharma Main Business Overview

        13.3.5 Mylan Pharma Latest Developments

    13.4 Apotex

        13.4.1 Apotex Company Information

        13.4.2 Apotex Amyotrophic Lateral Sclerosis (ALS) Product Portfolios and Specifications

        13.4.3 Apotex Amyotrophic Lateral Sclerosis (ALS) Sales, Revenue, Price and Gross Margin (2019-2024)

        13.4.4 Apotex Main Business Overview

        13.4.5 Apotex Latest Developments

    13.5 Glemark Generics

        13.5.1 Glemark Generics Company Information

        13.5.2 Glemark Generics Amyotrophic Lateral Sclerosis (ALS) Product Portfolios and Specifications

        13.5.3 Glemark Generics Amyotrophic Lateral Sclerosis (ALS) Sales, Revenue, Price and Gross Margin (2019-2024)

        13.5.4 Glemark Generics Main Business Overview

        13.5.5 Glemark Generics Latest Developments

    13.6 Covis Pharma

        13.6.1 Covis Pharma Company Information

        13.6.2 Covis Pharma Amyotrophic Lateral Sclerosis (ALS) Product Portfolios and Specifications

        13.6.3 Covis Pharma Amyotrophic Lateral Sclerosis (ALS) Sales, Revenue, Price and Gross Margin (2019-2024)

        13.6.4 Covis Pharma Main Business Overview

        13.6.5 Covis Pharma Latest Developments

    13.7 Sun Pharma

        13.7.1 Sun Pharma Company Information

        13.7.2 Sun Pharma Amyotrophic Lateral Sclerosis (ALS) Product Portfolios and Specifications

        13.7.3 Sun Pharma Amyotrophic Lateral Sclerosis (ALS) Sales, Revenue, Price and Gross Margin (2019-2024)

        13.7.4 Sun Pharma Main Business Overview

        13.7.5 Sun Pharma Latest Developments

    13.8 Lunan Pharma

        13.8.1 Lunan Pharma Company Information

        13.8.2 Lunan Pharma Amyotrophic Lateral Sclerosis (ALS) Product Portfolios and Specifications

        13.8.3 Lunan Pharma Amyotrophic Lateral Sclerosis (ALS) Sales, Revenue, Price and Gross Margin (2019-2024)

        13.8.4 Lunan Pharma Main Business Overview

        13.8.5 Lunan Pharma Latest Developments

14 Research Findings and Conclusion


List of Tables

    Table 1. Amyotrophic Lateral Sclerosis (ALS) Annual Sales CAGR by Geographic Region (2019, 2023 & 2030) & ($ millions)

    Table 2. Amyotrophic Lateral Sclerosis (ALS) Annual Sales CAGR by Country/Region (2019, 2023 & 2030) & ($ millions)

    Table 3. Major Players of Riluzole

    Table 4. Major Players of Edaravone (Radicava)

    Table 5. Major Players of Other

    Table 6. Global Amyotrophic Lateral Sclerosis (ALS) Sales by Type (2019-2024) & (K Unit)

    Table 7. Global Amyotrophic Lateral Sclerosis (ALS) Sales Market Share by Type (2019-2024)

    Table 8. Global Amyotrophic Lateral Sclerosis (ALS) Revenue by Type (2019-2024) & ($ million)

    Table 9. Global Amyotrophic Lateral Sclerosis (ALS) Revenue Market Share by Type (2019-2024)

    Table 10. Global Amyotrophic Lateral Sclerosis (ALS) Sale Price by Type (2019-2024) & (USD/Unit)

    Table 11. Global Amyotrophic Lateral Sclerosis (ALS) Sales by Application (2019-2024) & (K Unit)

    Table 12. Global Amyotrophic Lateral Sclerosis (ALS) Sales Market Share by Application (2019-2024)

    Table 13. Global Amyotrophic Lateral Sclerosis (ALS) Revenue by Application (2019-2024)

    Table 14. Global Amyotrophic Lateral Sclerosis (ALS) Revenue Market Share by Application (2019-2024)

    Table 15. Global Amyotrophic Lateral Sclerosis (ALS) Sale Price by Application (2019-2024) & (USD/Unit)

    Table 16. Global Amyotrophic Lateral Sclerosis (ALS) Sales by Company (2019-2024) & (K Unit)

    Table 17. Global Amyotrophic Lateral Sclerosis (ALS) Sales Market Share by Company (2019-2024)

    Table 18. Global Amyotrophic Lateral Sclerosis (ALS) Revenue by Company (2019-2024) ($ Millions)

    Table 19. Global Amyotrophic Lateral Sclerosis (ALS) Revenue Market Share by Company (2019-2024)

    Table 20. Global Amyotrophic Lateral Sclerosis (ALS) Sale Price by Company (2019-2024) & (USD/Unit)

    Table 21. Key Manufacturers Amyotrophic Lateral Sclerosis (ALS) Producing Area Distribution and Sales Area

    Table 22. Players Amyotrophic Lateral Sclerosis (ALS) Products Offered

    Table 23. Amyotrophic Lateral Sclerosis (ALS) Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)

    Table 24. New Products and Potential Entrants

    Table 25. Mergers & Acquisitions, Expansion

    Table 26. Global Amyotrophic Lateral Sclerosis (ALS) Sales by Geographic Region (2019-2024) & (K Unit)

    Table 27. Global Amyotrophic Lateral Sclerosis (ALS) Sales Market Share Geographic Region (2019-2024)

    Table 28. Global Amyotrophic Lateral Sclerosis (ALS) Revenue by Geographic Region (2019-2024) & ($ millions)

    Table 29. Global Amyotrophic Lateral Sclerosis (ALS) Revenue Market Share by Geographic Region (2019-2024)

    Table 30. Global Amyotrophic Lateral Sclerosis (ALS) Sales by Country/Region (2019-2024) & (K Unit)

    Table 31. Global Amyotrophic Lateral Sclerosis (ALS) Sales Market Share by Country/Region (2019-2024)

    Table 32. Global Amyotrophic Lateral Sclerosis (ALS) Revenue by Country/Region (2019-2024) & ($ millions)

    Table 33. Global Amyotrophic Lateral Sclerosis (ALS) Revenue Market Share by Country/Region (2019-2024)

    Table 34. Americas Amyotrophic Lateral Sclerosis (ALS) Sales by Country (2019-2024) & (K Unit)

    Table 35. Americas Amyotrophic Lateral Sclerosis (ALS) Sales Market Share by Country (2019-2024)

    Table 36. Americas Amyotrophic Lateral Sclerosis (ALS) Revenue by Country (2019-2024) & ($ Millions)

    Table 37. Americas Amyotrophic Lateral Sclerosis (ALS) Revenue Market Share by Country (2019-2024)

    Table 38. Americas Amyotrophic Lateral Sclerosis (ALS) Sales by Type (2019-2024) & (K Unit)

    Table 39. Americas Amyotrophic Lateral Sclerosis (ALS) Sales by Application (2019-2024) & (K Unit)

    Table 40. APAC Amyotrophic Lateral Sclerosis (ALS) Sales by Region (2019-2024) & (K Unit)

    Table 41. APAC Amyotrophic Lateral Sclerosis (ALS) Sales Market Share by Region (2019-2024)

    Table 42. APAC Amyotrophic Lateral Sclerosis (ALS) Revenue by Region (2019-2024) & ($ Millions)

    Table 43. APAC Amyotrophic Lateral Sclerosis (ALS) Revenue Market Share by Region (2019-2024)

    Table 44. APAC Amyotrophic Lateral Sclerosis (ALS) Sales by Type (2019-2024) & (K Unit)

    Table 45. APAC Amyotrophic Lateral Sclerosis (ALS) Sales by Application (2019-2024) & (K Unit)

    Table 46. Europe Amyotrophic Lateral Sclerosis (ALS) Sales by Country (2019-2024) & (K Unit)

    Table 47. Europe Amyotrophic Lateral Sclerosis (ALS) Sales Market Share by Country (2019-2024)

    Table 48. Europe Amyotrophic Lateral Sclerosis (ALS) Revenue by Country (2019-2024) & ($ Millions)

    Table 49. Europe Amyotrophic Lateral Sclerosis (ALS) Revenue Market Share by Country (2019-2024)

    Table 50. Europe Amyotrophic Lateral Sclerosis (ALS) Sales by Type (2019-2024) & (K Unit)

    Table 51. Europe Amyotrophic Lateral Sclerosis (ALS) Sales by Application (2019-2024) & (K Unit)

    Table 52. Middle East & Africa Amyotrophic Lateral Sclerosis (ALS) Sales by Country (2019-2024) & (K Unit)

    Table 53. Middle East & Africa Amyotrophic Lateral Sclerosis (ALS) Sales Market Share by Country (2019-2024)

    Table 54. Middle East & Africa Amyotrophic Lateral Sclerosis (ALS) Revenue by Country (2019-2024) & ($ Millions)

    Table 55. Middle East & Africa Amyotrophic Lateral Sclerosis (ALS) Revenue Market Share by Country (2019-2024)

    Table 56. Middle East & Africa Amyotrophic Lateral Sclerosis (ALS) Sales by Type (2019-2024) & (K Unit)

    Table 57. Middle East & Africa Amyotrophic Lateral Sclerosis (ALS) Sales by Application (2019-2024) & (K Unit)

    Table 58. Key Market Drivers & Growth Opportunities of Amyotrophic Lateral Sclerosis (ALS)

    Table 59. Key Market Challenges & Risks of Amyotrophic Lateral Sclerosis (ALS)

    Table 60. Key Industry Trends of Amyotrophic Lateral Sclerosis (ALS)

    Table 61. Amyotrophic Lateral Sclerosis (ALS) Raw Material

    Table 62. Key Suppliers of Raw Materials

    Table 63. Amyotrophic Lateral Sclerosis (ALS) Distributors List

    Table 64. Amyotrophic Lateral Sclerosis (ALS) Customer List

    Table 65. Global Amyotrophic Lateral Sclerosis (ALS) Sales Forecast by Region (2025-2030) & (K Unit)

    Table 66. Global Amyotrophic Lateral Sclerosis (ALS) Revenue Forecast by Region (2025-2030) & ($ millions)

    Table 67. Americas Amyotrophic Lateral Sclerosis (ALS) Sales Forecast by Country (2025-2030) & (K Unit)

    Table 68. Americas Amyotrophic Lateral Sclerosis (ALS) Revenue Forecast by Country (2025-2030) & ($ millions)

    Table 69. APAC Amyotrophic Lateral Sclerosis (ALS) Sales Forecast by Region (2025-2030) & (K Unit)

    Table 70. APAC Amyotrophic Lateral Sclerosis (ALS) Revenue Forecast by Region (2025-2030) & ($ millions)

    Table 71. Europe Amyotrophic Lateral Sclerosis (ALS) Sales Forecast by Country (2025-2030) & (K Unit)

    Table 72. Europe Amyotrophic Lateral Sclerosis (ALS) Revenue Forecast by Country (2025-2030) & ($ millions)

    Table 73. Middle East & Africa Amyotrophic Lateral Sclerosis (ALS) Sales Forecast by Country (2025-2030) & (K Unit)

    Table 74. Middle East & Africa Amyotrophic Lateral Sclerosis (ALS) Revenue Forecast by Country (2025-2030) & ($ millions)

    Table 75. Global Amyotrophic Lateral Sclerosis (ALS) Sales Forecast by Type (2025-2030) & (K Unit)

    Table 76. Global Amyotrophic Lateral Sclerosis (ALS) Revenue Forecast by Type (2025-2030) & ($ Millions)

    Table 77. Global Amyotrophic Lateral Sclerosis (ALS) Sales Forecast by Application (2025-2030) & (K Unit)

    Table 78. Global Amyotrophic Lateral Sclerosis (ALS) Revenue Forecast by Application (2025-2030) & ($ Millions)

    Table 79. Mitsubishi Tanabe Pharma Basic Information, Amyotrophic Lateral Sclerosis (ALS) Manufacturing Base, Sales Area and Its Competitors

    Table 80. Mitsubishi Tanabe Pharma Amyotrophic Lateral Sclerosis (ALS) Product Portfolios and Specifications

    Table 81. Mitsubishi Tanabe Pharma Amyotrophic Lateral Sclerosis (ALS) Sales (K Unit), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)

    Table 82. Mitsubishi Tanabe Pharma Main Business

    Table 83. Mitsubishi Tanabe Pharma Latest Developments

    Table 84. Sanofi Basic Information, Amyotrophic Lateral Sclerosis (ALS) Manufacturing Base, Sales Area and Its Competitors

    Table 85. Sanofi Amyotrophic Lateral Sclerosis (ALS) Product Portfolios and Specifications

    Table 86. Sanofi Amyotrophic Lateral Sclerosis (ALS) Sales (K Unit), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)

    Table 87. Sanofi Main Business

    Table 88. Sanofi Latest Developments

    Table 89. Mylan Pharma Basic Information, Amyotrophic Lateral Sclerosis (ALS) Manufacturing Base, Sales Area and Its Competitors

    Table 90. Mylan Pharma Amyotrophic Lateral Sclerosis (ALS) Product Portfolios and Specifications

    Table 91. Mylan Pharma Amyotrophic Lateral Sclerosis (ALS) Sales (K Unit), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)

    Table 92. Mylan Pharma Main Business

    Table 93. Mylan Pharma Latest Developments

    Table 94. Apotex Basic Information, Amyotrophic Lateral Sclerosis (ALS) Manufacturing Base, Sales Area and Its Competitors

    Table 95. Apotex Amyotrophic Lateral Sclerosis (ALS) Product Portfolios and Specifications

    Table 96. Apotex Amyotrophic Lateral Sclerosis (ALS) Sales (K Unit), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)

    Table 97. Apotex Main Business

    Table 98. Apotex Latest Developments

    Table 99. Glemark Generics Basic Information, Amyotrophic Lateral Sclerosis (ALS) Manufacturing Base, Sales Area and Its Competitors

    Table 100. Glemark Generics Amyotrophic Lateral Sclerosis (ALS) Product Portfolios and Specifications

    Table 101. Glemark Generics Amyotrophic Lateral Sclerosis (ALS) Sales (K Unit), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)

    Table 102. Glemark Generics Main Business

    Table 103. Glemark Generics Latest Developments

    Table 104. Covis Pharma Basic Information, Amyotrophic Lateral Sclerosis (ALS) Manufacturing Base, Sales Area and Its Competitors

    Table 105. Covis Pharma Amyotrophic Lateral Sclerosis (ALS) Product Portfolios and Specifications

    Table 106. Covis Pharma Amyotrophic Lateral Sclerosis (ALS) Sales (K Unit), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)

    Table 107. Covis Pharma Main Business

    Table 108. Covis Pharma Latest Developments

    Table 109. Sun Pharma Basic Information, Amyotrophic Lateral Sclerosis (ALS) Manufacturing Base, Sales Area and Its Competitors

    Table 110. Sun Pharma Amyotrophic Lateral Sclerosis (ALS) Product Portfolios and Specifications

    Table 111. Sun Pharma Amyotrophic Lateral Sclerosis (ALS) Sales (K Unit), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)

    Table 112. Sun Pharma Main Business

    Table 113. Sun Pharma Latest Developments

    Table 114. Lunan Pharma Basic Information, Amyotrophic Lateral Sclerosis (ALS) Manufacturing Base, Sales Area and Its Competitors

    Table 115. Lunan Pharma Amyotrophic Lateral Sclerosis (ALS) Product Portfolios and Specifications

    Table 116. Lunan Pharma Amyotrophic Lateral Sclerosis (ALS) Sales (K Unit), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)

    Table 117. Lunan Pharma Main Business

    Table 118. Lunan Pharma Latest Developments

List of Figures

    Figure 1. Picture of Amyotrophic Lateral Sclerosis (ALS)

    Figure 2. Amyotrophic Lateral Sclerosis (ALS) Report Years Considered

    Figure 3. Research Objectives

    Figure 4. Research Methodology

    Figure 5. Research Process and Data Source

    Figure 6. Global Amyotrophic Lateral Sclerosis (ALS) Sales Growth Rate 2019-2030 (K Unit)

    Figure 7. Global Amyotrophic Lateral Sclerosis (ALS) Revenue Growth Rate 2019-2030 ($ Millions)

    Figure 8. Amyotrophic Lateral Sclerosis (ALS) Sales by Region (2019, 2023 & 2030) & ($ Millions)

    Figure 9. Product Picture of Riluzole

    Figure 10. Product Picture of Edaravone (Radicava)

    Figure 11. Product Picture of Other

    Figure 12. Global Amyotrophic Lateral Sclerosis (ALS) Sales Market Share by Type in 2023

    Figure 13. Global Amyotrophic Lateral Sclerosis (ALS) Revenue Market Share by Type (2019-2024)

    Figure 14. Amyotrophic Lateral Sclerosis (ALS) Consumed in Hospital

    Figure 15. Global Amyotrophic Lateral Sclerosis (ALS) Market: Hospital (2019-2024) & (K Unit)

    Figure 16. Amyotrophic Lateral Sclerosis (ALS) Consumed in Drugs Store

    Figure 17. Global Amyotrophic Lateral Sclerosis (ALS) Market: Drugs Store (2019-2024) & (K Unit)

    Figure 18. Amyotrophic Lateral Sclerosis (ALS) Consumed in Other

    Figure 19. Global Amyotrophic Lateral Sclerosis (ALS) Market: Other (2019-2024) & (K Unit)

    Figure 20. Global Amyotrophic Lateral Sclerosis (ALS) Sales Market Share by Application (2023)

    Figure 21. Global Amyotrophic Lateral Sclerosis (ALS) Revenue Market Share by Application in 2023

    Figure 22. Amyotrophic Lateral Sclerosis (ALS) Sales Market by Company in 2023 (K Unit)

    Figure 23. Global Amyotrophic Lateral Sclerosis (ALS) Sales Market Share by Company in 2023

    Figure 24. Amyotrophic Lateral Sclerosis (ALS) Revenue Market by Company in 2023 ($ Million)

    Figure 25. Global Amyotrophic Lateral Sclerosis (ALS) Revenue Market Share by Company in 2023

    Figure 26. Global Amyotrophic Lateral Sclerosis (ALS) Sales Market Share by Geographic Region (2019-2024)

    Figure 27. Global Amyotrophic Lateral Sclerosis (ALS) Revenue Market Share by Geographic Region in 2023

    Figure 28. Americas Amyotrophic Lateral Sclerosis (ALS) Sales 2019-2024 (K Unit)

    Figure 29. Americas Amyotrophic Lateral Sclerosis (ALS) Revenue 2019-2024 ($ Millions)

    Figure 30. APAC Amyotrophic Lateral Sclerosis (ALS) Sales 2019-2024 (K Unit)

    Figure 31. APAC Amyotrophic Lateral Sclerosis (ALS) Revenue 2019-2024 ($ Millions)

    Figure 32. Europe Amyotrophic Lateral Sclerosis (ALS) Sales 2019-2024 (K Unit)

    Figure 33. Europe Amyotrophic Lateral Sclerosis (ALS) Revenue 2019-2024 ($ Millions)

    Figure 34. Middle East & Africa Amyotrophic Lateral Sclerosis (ALS) Sales 2019-2024 (K Unit)

    Figure 35. Middle East & Africa Amyotrophic Lateral Sclerosis (ALS) Revenue 2019-2024 ($ Millions)

    Figure 36. Americas Amyotrophic Lateral Sclerosis (ALS) Sales Market Share by Country in 2023

    Figure 37. Americas Amyotrophic Lateral Sclerosis (ALS) Revenue Market Share by Country in 2023

    Figure 38. Americas Amyotrophic Lateral Sclerosis (ALS) Sales Market Share by Type (2019-2024)

    Figure 39. Americas Amyotrophic Lateral Sclerosis (ALS) Sales Market Share by Application (2019-2024)

    Figure 40. United States Amyotrophic Lateral Sclerosis (ALS) Revenue Growth 2019-2024 ($ Millions)

    Figure 41. Canada Amyotrophic Lateral Sclerosis (ALS) Revenue Growth 2019-2024 ($ Millions)

    Figure 42. Mexico Amyotrophic Lateral Sclerosis (ALS) Revenue Growth 2019-2024 ($ Millions)

    Figure 43. Brazil Amyotrophic Lateral Sclerosis (ALS) Revenue Growth 2019-2024 ($ Millions)

    Figure 44. APAC Amyotrophic Lateral Sclerosis (ALS) Sales Market Share by Region in 2023

    Figure 45. APAC Amyotrophic Lateral Sclerosis (ALS) Revenue Market Share by Regions in 2023

    Figure 46. APAC Amyotrophic Lateral Sclerosis (ALS) Sales Market Share by Type (2019-2024)

    Figure 47. APAC Amyotrophic Lateral Sclerosis (ALS) Sales Market Share by Application (2019-2024)

    Figure 48. China Amyotrophic Lateral Sclerosis (ALS) Revenue Growth 2019-2024 ($ Millions)

    Figure 49. Japan Amyotrophic Lateral Sclerosis (ALS) Revenue Growth 2019-2024 ($ Millions)

    Figure 50. South Korea Amyotrophic Lateral Sclerosis (ALS) Revenue Growth 2019-2024 ($ Millions)

    Figure 51. Southeast Asia Amyotrophic Lateral Sclerosis (ALS) Revenue Growth 2019-2024 ($ Millions)

    Figure 52. India Amyotrophic Lateral Sclerosis (ALS) Revenue Growth 2019-2024 ($ Millions)

    Figure 53. Australia Amyotrophic Lateral Sclerosis (ALS) Revenue Growth 2019-2024 ($ Millions)

    Figure 54. China Taiwan Amyotrophic Lateral Sclerosis (ALS) Revenue Growth 2019-2024 ($ Millions)

    Figure 55. Europe Amyotrophic Lateral Sclerosis (ALS) Sales Market Share by Country in 2023

    Figure 56. Europe Amyotrophic Lateral Sclerosis (ALS) Revenue Market Share by Country in 2023

    Figure 57. Europe Amyotrophic Lateral Sclerosis (ALS) Sales Market Share by Type (2019-2024)

    Figure 58. Europe Amyotrophic Lateral Sclerosis (ALS) Sales Market Share by Application (2019-2024)

    Figure 59. Germany Amyotrophic Lateral Sclerosis (ALS) Revenue Growth 2019-2024 ($ Millions)

    Figure 60. France Amyotrophic Lateral Sclerosis (ALS) Revenue Growth 2019-2024 ($ Millions)

    Figure 61. UK Amyotrophic Lateral Sclerosis (ALS) Revenue Growth 2019-2024 ($ Millions)

    Figure 62. Italy Amyotrophic Lateral Sclerosis (ALS) Revenue Growth 2019-2024 ($ Millions)

    Figure 63. Russia Amyotrophic Lateral Sclerosis (ALS) Revenue Growth 2019-2024 ($ Millions)

    Figure 64. Middle East & Africa Amyotrophic Lateral Sclerosis (ALS) Sales Market Share by Country in 2023

    Figure 65. Middle East & Africa Amyotrophic Lateral Sclerosis (ALS) Revenue Market Share by Country in 2023

    Figure 66. Middle East & Africa Amyotrophic Lateral Sclerosis (ALS) Sales Market Share by Type (2019-2024)

    Figure 67. Middle East & Africa Amyotrophic Lateral Sclerosis (ALS) Sales Market Share by Application (2019-2024)

    Figure 68. Egypt Amyotrophic Lateral Sclerosis (ALS) Revenue Growth 2019-2024 ($ Millions)

    Figure 69. South Africa Amyotrophic Lateral Sclerosis (ALS) Revenue Growth 2019-2024 ($ Millions)

    Figure 70. Israel Amyotrophic Lateral Sclerosis (ALS) Revenue Growth 2019-2024 ($ Millions)

    Figure 71. Turkey Amyotrophic Lateral Sclerosis (ALS) Revenue Growth 2019-2024 ($ Millions)

    Figure 72. GCC Country Amyotrophic Lateral Sclerosis (ALS) Revenue Growth 2019-2024 ($ Millions)

    Figure 73. Manufacturing Cost Structure Analysis of Amyotrophic Lateral Sclerosis (ALS) in 2023

    Figure 74. Manufacturing Process Analysis of Amyotrophic Lateral Sclerosis (ALS)

    Figure 75. Industry Chain Structure of Amyotrophic Lateral Sclerosis (ALS)

    Figure 76. Channels of Distribution

    Figure 77. Global Amyotrophic Lateral Sclerosis (ALS) Sales Market Forecast by Region (2025-2030)

    Figure 78. Global Amyotrophic Lateral Sclerosis (ALS) Revenue Market Share Forecast by Region (2025-2030)

    Figure 79. Global Amyotrophic Lateral Sclerosis (ALS) Sales Market Share Forecast by Type (2025-2030)

    Figure 80. Global Amyotrophic Lateral Sclerosis (ALS) Revenue Market Share Forecast by Type (2025-2030)

    Figure 81. Global Amyotrophic Lateral Sclerosis (ALS) Sales Market Share Forecast by Application (2025-2030)

    Figure 82. Global Amyotrophic Lateral Sclerosis (ALS) Revenue Market Share Forecast by Application (2025-2030)
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
"Mitsubishi Tanabe Pharma"|||"Sanofi"|||"Mylan Pharma"|||"Apotex"|||"Glemark Generics"|||"Covis Pharma"|||"Sun Pharma"|||"Lunan Pharma"
Frequently Asked Questions
Amyotrophic Lateral Sclerosis (ALS) report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Amyotrophic Lateral Sclerosis (ALS) report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Amyotrophic Lateral Sclerosis (ALS) report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports